0 CHECKOUT

PRODUCT FILTERS

REGION

8
3
3
3
2

COUNTRY

3
1

CATEGORIES

  • 13
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

11
13
14
17

PUBLISHED

0
4
8
17

PRODUCT TYPE

6
4
4
2
1

Search for: "Jazz Pharmaceuticals, Inc.-Deals & Alliances Report"

Jazz Pharmaceuticals plc (formerly Jazz Pharmaceuticals, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

The Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization...

Published:  March 2016
Price:  From

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

The Global Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

Published:  February 2016
Price:  From

AMAG Pharmaceuticals, Inc. (AMAG) - Financial and Strategic SWOT Analysis Review

AMAG Pharmaceuticals, Inc. (AMAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  April 2016
Price:  From

Pacira Pharmaceuticals, Inc. (PCRX) - Financial and Strategic SWOT Analysis Review

Pacira Pharmaceuticals, Inc. (PCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  April 2016
Price:  From

Orphan Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Orphan Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts...

Published:  April 2015
Price:  From

Vivus, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review

Vivus, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher...

Published:  May 2015
Price:  From

Valeant Pharmaceuticals International - Product Pipeline Review - Q4 2010

Valeant Pharmaceuticals International – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Valeant Pharmaceuticals International - Product Pipeline Review -...

Published:  December 2010
Price:  From

Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - H2 2011

Valeant Pharmaceuticals International, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Valeant Pharmaceuticals International, Inc. - Product Pipeline...

Published:  November 2011
Price:  From

Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review

Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review Summary Par Pharmaceutical Companies, Inc. (Par Pharmaceutical) is a publicly traded pharmaceutical company....

Published:  March 2012
Price:  From

Industry Report Card: The Outlook For U.S. For-Profit Health Care Companies Is Stable, As They Face Challenging Industry Changes In 2013 May 13

Abstract Standard & Poor's Ratings Services expects its ratings on the U.S. for-profit health care companies it rates to remain broadly stable in 2013, with a modest negative bias, primarily in the...

Published:  May 2013
Price: 

North American Corporate Rating Scores By Industry Sector As Of March 5, 2015 May 15

Abstract Standard & Poor's Ratings Services is updating the rating component scores for its public corporate credit ratings in North America. This article follows a similar report published on Feb....

Published:  May 2015
Price: 

Prescription Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors,...

Published:  July 2009
Price:  From

Asia-Pacific And Latin America Amassed Debt At A Far Faster Pace Than Europe And North America, Says S&P Report Jan 16

Abstract MELBOURNE (Standard & Poor's) Jan. 14, 2016-Debt growth in Asia-Pacific and Latin America has outstripped the regions' GDP expansion during 2009-2015 at a far faster pace than that in Europe...

Published:  January 2016
Price: 

Negative Outlooks On Global Corporates Exceed Positive Ones By The Widest Margin Since 2009, Says S&P Report Jan 16

Abstract MELBOURNE (Standard & Poor's) Jan. 12, 2016--The net outlook bias is a negative 11%, which is the worst level since the 2008-2009 financial crisis. That's according to a report by Standard...

Published:  January 2016
Price: 

Global Corporate Debt Demand Declines To $57 Trillion As Credit Risk Concentrates In China, U.S. Jul 15

Abstract MELBOURNE (Standard & Poor's) July 16, 2015--Global corporate debt demand will peak at an estimated $57 trillion by 2019, a decline of 4% from last year's projection, according to an annual...

Published:  July 2015
Price: 

Record Low Cost Of Capital Could Boost European M&A While Risks To Credit Quality Are Expected To Rise, Says Report Apr 16

Abstract LONDON (Standard & Poor's) April 29, 2016--While we continue to see Europe-domiciled companies remaining somewhat conservative in their use of fully-debt financed acquisitions, conditions...

Published:  April 2016
Price: 

Soft Drinks - Global Strategic Business Report

This report analyzes the worldwide markets for Soft Drinks in Millions of Liters and US$ Million The major product segments analyzed are Carbonates, and Non-Carbonates The sub product segments analyzed...

Published:  February 2006
Price:  From
Loading Indicator

Our Clients

  • Credit Suisse Group
  • Heinz Company
  • Telenor Group
  • Deutsche Bank AG
  • Solvay S.A.
  • APC by Schneider Electric
  • Lindt & Sprüngli AG